Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity (Q35209850)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity (English)

1 reference

Europe PubMed Central

7 August 2017

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Shirya Rashid

1

1 reference

Europe PubMed Central

7 August 2017

Takehiko Watanabe

2

1 reference

Europe PubMed Central

7 August 2017

Taro Sakaue

3

1 reference

Europe PubMed Central

7 August 2017

Gary F Lewis

4

1 reference

Europe PubMed Central

7 August 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

7 August 2017

Clinical Biochemistry

1 reference

Europe PubMed Central

7 August 2017

36

1 reference

Europe PubMed Central

7 August 2017

421-429

1 reference

Europe PubMed Central

7 August 2017

6

1 reference

Europe PubMed Central

7 August 2017

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

HDL metabolism in hypertriglyceridemic states: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

HDL and arteriosclerosis: beyond reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Role of lipoprotein lipases in postprandial lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-contain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Insulin resistance and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Overexpression of muscle lipoprotein lipase and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Regional similarities in the metabolic regulation of adipose tissue lipoprotein lipase.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Lipoprotein lipase: genetics, lipid uptake, and regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Lipases and HDL metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

A novel endothelial-derived lipase that modulates HDL metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

The hepatic heparin releasable lipase binds to high density lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Hydrolysis of human plasma high density lipoprotein2-phospholipids and triglycerides by hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

The role of hepatic lipase in lipoprotein metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Expression of human hepatic lipase in the rabbit model preferentially enhances the clearance of triglyceride-enriched versus native high-density lipoprotein apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HEPG2).

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Retroendocytosis of high density lipoproteins by the human hepatoma cell line, HepG2.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Biochemical demonstration of endocytosis and subsequent resecretion of high-density lipoprotein by rat peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

High-density lipoprotein 3 retroendocytosis: A new lipoprotein pathway in the enterocyte (Caco-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

The low density lipoprotein receptor-related protein contributes to selective uptake of high density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Hepatic lipase: a pro- or anti-atherogenic protein?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900078-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-9120(03)00078-X

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35209850&oldid=1574801880"